CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Unrecognized Tax Benefits, Decrease Resulting from Acquisition
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Unrecognized Tax Benefits, Decrease Resulting from Acquisition of $10.40 million for the 12-month period ending 2015-12-26, per its 10-K filed 2016-02-12.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromAcquisition · last filed 2016-02-12
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, decrease resulting from acquisition for the quarter ending 2015-12-26 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, decrease resulting from acquisition for the quarter ending 2015-09-26 was $1.40M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, decrease resulting from acquisition for fiscal 2015 was $10.40M.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Acquisition 3 month | Unrecognized Tax Benefits, Decrease Resulting from Acquisition 6 month | Unrecognized Tax Benefits, Decrease Resulting from Acquisition 9 month | Unrecognized Tax Benefits, Decrease Resulting from Acquisition 12 month |
|---|---|---|---|---|
| 2015-12-26 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $1.40M derived: sum of 2 quarters · filed 2016-02-12 | $10.40M 10-K · filed 2016-02-12 | |
| 2015-09-26 | $1.40M 10-Q · filed 2015-11-04 | $10.40M 10-Q · filed 2015-11-04 | ||
| 2015-06-27 | $10.40M 10-Q · filed 2015-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |